STOCK TITAN

Invivyd to Participate in the Guggenheim Securities Healthcare Innovation Conference

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Invivyd (Nasdaq: IVVD) has announced its participation in the upcoming Guggenheim Securities Healthcare Innovation Conference in Boston, MA. The company's management will engage in a fireside chat scheduled for Wednesday, November 13, 2024, at 2:30 PM ET, along with conducting one-on-one investor meetings during the conference, which runs from November 11-13, 2024.

A live webcast of the presentation will be accessible through the investor section of Invivyd's website and will remain available for approximately 30 days after the event.

Loading...
Loading translation...
Argus Session date unavailable
+12.62% session move Open Argus
Details

News Market Reaction – IVVD

The recorded move for IVVD in the trading session of this news was +12.62%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

WALTHAM, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that management will participate in a fireside chat and 1x1 investor meetings at the Guggenheim Securities Healthcare Innovation Conference taking place November 11-13, 2024.

Fireside Chat: Wednesday, November 13, 2024 at 2:30 PM ET
Location: Boston, MA

The live webcast link will be available in the investor section of the company's website at https://investors.invivyd.com and will be archived for approximately 30 days following the event.

About Invivyd
Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. The company’s proprietary INVYMAB™ platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs) to address evolving viral threats. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for its first mAb in a planned series of innovative antibody candidates. Visit https://invivyd.com/ to learn more.

Contacts:
Media Relations
(781) 208-1747
media@invivyd.com

Investor Relations
(781) 208-1747
investors@invivyd.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Invivyd (IVVD) presenting at the Guggenheim Securities Healthcare Conference 2024?

Invivyd (IVVD) will present in a fireside chat on Wednesday, November 13, 2024, at 2:30 PM ET.

Where can I watch Invivyd's (IVVD) Guggenheim Securities Conference presentation?

The presentation can be watched via live webcast on Invivyd's investor website at https://investors.invivyd.com and will be archived for about 30 days.

What type of meetings will Invivyd (IVVD) conduct at the Guggenheim Healthcare Conference?

Invivyd will participate in a fireside chat and conduct one-on-one investor meetings during the conference.

How long will Invivyd's (IVVD) Guggenheim Conference presentation be available online?

The presentation webcast will be archived and available for approximately 30 days following the event.

Keep reading